Meta Pixel

News and Announcements

Book List on Angel Investing

  • Published December 14, 2022 6:49AM UTC
  • Publisher Osama Hassan
  • Categories Capital Raising Tips

I just came across Cheryl Mack‘s book list on angel investing and thought it’d make for a great share.

Here we go:

1 – Secrets of Sand Hill Road by Scott Kupor

On how VCs decide where and how much to invest, and how entrepreneurs can get the best possible deal. Written for founders but super useful for Angels.

2 – Angel Investing by David S. Rose

The author is CEO of Gust & founder of New York Angels. Tons of great learnings in here!

3 – Venture Deals: Be Smarter Than Your Lawyer and Venture Capitalist by Brad Feld

This one is written for founders and goes much more into venture stage deals. It’s useful to understand the whole process that the startups you’re considering investing in are going to go through.

4 – ANGEL by Jason Calacanis

How to Invest in Technology Startups — Timeless Advice from an Angel Investor Who Turned $100,000 Into $100,000,000. Jason is known as a super angel and this is his playbook for investing in startups!

5 – The Business of Venture Capital by Mahendra R.

Since its initial publication, The Business of Venture Capital has been hailed as the definitive, most comprehensive book on the subject.

Do you have any books you’d like to add to this list?

Thanks for sharing your booklist, Cheryl. For those interested, Cheryl is CEO at Aussie Angels, Co-Director at Founder Institute (Australia & New Zealand), and startup mentor at Startmate. She’s got an excellent website with heaps of useful resources that you can check out here: https://lnkd.in/gY77XZDv

Click here to view the original Linkedin post.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now